CLEARSIDE BIOMEDICAL INC's ticker is and the CUSIP is 185063904. A total of 3 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -23.5% | 30,000 | -2.9% | 0.00% | – |
| Q2 2023 | $34 | -2.9% | 30,900 | -10.2% | 0.00% | – |
| Q1 2023 | $35 | -37.5% | 34,400 | -32.3% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 50,800 | +45.1% | 0.00% | – |
| Q3 2022 | $39,000 | +69.6% | 35,000 | +120.1% | 0.00% | – |
| Q2 2022 | $23,000 | -59.6% | 15,900 | -36.9% | 0.00% | – |
| Q1 2022 | $57,000 | +470.0% | 25,200 | +546.2% | 0.00% | – |
| Q4 2021 | $10,000 | -96.6% | 3,900 | -93.6% | 0.00% | – |
| Q3 2021 | $295,000 | -1.0% | 61,200 | 0.0% | 0.00% | – |
| Q2 2021 | $298,000 | +313.9% | 61,200 | +20716.3% | 0.00% | – |
| Q1 2021 | $72,000 | – | 294 | +1447.4% | 0.00% | – |
| Q4 2020 | $0 | – | 19 | -90.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 190 | +1087.5% | 0.00% | – |
| Q2 2020 | $3,000 | -50.0% | 16 | -57.9% | 0.00% | – |
| Q1 2020 | $6,000 | +100.0% | 38 | +192.3% | 0.00% | – |
| Q4 2019 | $3,000 | -76.9% | 13 | -90.5% | 0.00% | – |
| Q2 2019 | $13,000 | +116.7% | 137 | +179.6% | 0.00% | – |
| Q1 2019 | $6,000 | -25.0% | 49 | -38.8% | 0.00% | – |
| Q4 2018 | $8,000 | -84.0% | 80 | +70.2% | 0.00% | – |
| Q2 2018 | $50,000 | +900.0% | 47 | +34.3% | 0.00% | – |
| Q1 2018 | $5,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,600 | $4,000 | 0.00% |
| SIMPLEX TRADING, LLC | 19 | $0 | 0.00% |